Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial

(1) Background: This study aimed to compare the immunogenicity of the mix-and-match CoronaVac/BNT162b2 vaccination to the homologous CoronaVac/CoronaVac regimen. (2) Methods: We conducted a simple-blinded randomized superiority trial to measure SARS-CoV-2 neutralization antibodies and anti-spike rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Samoud, Samar, Bettaieb, Jihene, Gdoura, Mariem, Kharroubi, Ghassen, Ben Ghachem, Feriel, Zamali, Imen, Ben Hmid, Ahlem, Salem, Sadok, Gereisha, Ahmed Adel, Dellagi, Mongi, Hogga, Nahed, Gharbi, Adel, Baccouche, Amor, Gharbi, Manel, Khemissi, Chadha, Akili, Ghada, Slama, Wissem, Chaieb, Nabila, Galai, Yousr, Louzir, Hechmi, Triki, Henda, Ben Ahmed, Melika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459159/
https://www.ncbi.nlm.nih.gov/pubmed/37631897
http://dx.doi.org/10.3390/vaccines11081329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459159/
https://www.ncbi.nlm.nih.gov/pubmed/37631897
http://dx.doi.org/10.3390/vaccines11081329

Ejemplares similares